Karl Anderson, MD

Projects

Projects per year 1900 2013 2016 2018 2021 2027

• 15 Active
• 45 Completed

Projects per year

Search results

• Active

  Acute Porphyrias: Biomarkers for Disease Activity and Response to Treatment

  Anderson, K.

  Recordati Rare Diseases Inc

  2/9/23 → 2/8/24

  Project: Other project

• A Randomized, Double-blind, Placebo-Controlled Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and Protoporphyrin IX (PPIX) Concentrations in Participants with Erythropoietic Protoporphyria (EPP)

  Anderson, K.

  Disc Medicine Inc

  10/27/22 → 10/26/27

  Project: Other project

• Safety and Efficacy of Panhematin for Prevention of Acute Attacks of Porphyria

  Anderson, K.

  12/13/21 → 12/12/23

  Project: Other project

• A Phase 3, Multicenter, Open-Label, Long-Term, Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

  Anderson, K.

  Mitsubishi Tanabe Pharma

  10/25/21 → 10/24/26

  Project: Other project

• A Phase 3, Multicenter, Open-Label, Long-Term, Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

  Anderson, K.

  10/25/21 → 10/24/26

  Project: Other project

• Alnylam Pharmaceuticals, Inc. - 0306060, Assessing Patients' Experiences With Acute Hepatic Porphyria: Exit Interviews (Pro00053618)

  Anderson, K.

  Alnylam Pharmaceuticals, Inc

  10/6/21 → 10/5/24

  Project: Other project

• Alnylam Pharmaceuticals, Inc. - 0306060, Assessing Patients' Experiences With Acute Hepatic Porphyria: Exit Interviews (Pro00053618)

  Anderson, K.

  10/6/21 → 10/5/24

  Project: Other project

• Effect of Oral Cimetidine in the Protoporphyrias (IND 152831 submitted 9/2/2020)

  Anderson, K.

  MASSACHUSETTS GENERAL HOSPITAL

  9/10/21 → 4/30/24

  Project: Other project

• ELEVATE, a global observational longitudinal prospective registry of patients with acute hepatic porphyria (AHP)

  Anderson, K.

  8/20/21 → 8/19/26

  Project: Other project

• ELEVATE, a global observational longitudinal prospective registry of patients with acute hepatic porphyria (AHP)

  Anderson, K.

  Alnylam Pharmaceuticals, Inc

  8/20/21 → 8/19/26

  Project: Other project

• RE- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of MT 7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X Linked Protoporphyria

  Anderson, K.

  5/15/21 → 9/16/25

  Project: Other project

• RE- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of MT 7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X Linked Protoporphyria

  Anderson, K.

  5/15/21 → 9/16/25

  Project: Other project

• RE: Porphyria Rare Disease Clinical Research Consortium (RDCRC)

  Anderson, K.

  5/14/21 → 6/30/24

  Project: Other project

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety and Tolerability of MT 7117 in Adults and Adolescents with Erythropoietic Protoporphyria or X Linked Protoporphyria

  Anderson, K.

  Mitsubishi Tanabe Pharma

  9/17/20 → 9/16/25

  Project: Other project

• A Natural History Study of Acute Hepatic Porphyria (AHP) Patients with Recurrent Attacks ALN-AS1-NT-001

  Anderson, K.

  8/14/14 → 12/31/23

  Project: Other project